One of the emerging companies whose new product development and marketing strategy we have been watching is AB Science. Sally Church on Pharma Strategy Blog has interviewed the CEO, Alain Moussy as part of her series on pharmaceutical, biotechnology industry leaders who are making a difference.
AB Science is a Paris based emerging pharmaceutical company. We think that they have some innovative approaches to new product development in oncology and inflammation.
Pieter Droppert on Biotech Strategy Blog has written the latest update in a series of posts about the company, their pipeline and clinical trials. AB Science is a company worth taking a look at.